These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 10970940

  • 1. [Evaluation of corticosteroid replacement therapy and its effect on bones in Addison's disease].
    Heureux F, Maiter D, Boutsen Y, Devogelaer JP, Jamart J, Donckier J.
    Ann Endocrinol (Paris); 2000 Sep; 61(3):179-83. PubMed ID: 10970940
    [Abstract] [Full Text] [Related]

  • 2. Bone mineral density in patients with treated Addison's disease.
    Braatvedt GD, Joyce M, Evans M, Clearwater J, Reid IR.
    Osteoporos Int; 1999 Sep; 10(6):435-40. PubMed ID: 10663342
    [Abstract] [Full Text] [Related]

  • 3. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M, Gryczyńska M, Sowińska A, Sowiński J.
    Przegl Lek; 2011 Sep; 68(2):96-102. PubMed ID: 21751518
    [Abstract] [Full Text] [Related]

  • 4. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.
    Løvås K, Gjesdal CG, Christensen M, Wolff AB, Almås B, Svartberg J, Fougner KJ, Syversen U, Bollerslev J, Falch JA, Hunt PJ, Chatterjee VK, Husebye ES.
    Eur J Endocrinol; 2009 Jun; 160(6):993-1002. PubMed ID: 19282465
    [Abstract] [Full Text] [Related]

  • 5. Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution.
    Fichna M, Zurawek M, Fichna P, Gryczynska M, Nowak J, Ruchala M.
    J Physiol Pharmacol; 2012 Dec; 63(6):677-82. PubMed ID: 23388484
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density is reduced in female but not male subjects with Addison's disease.
    Florkowski CM, Holmes SJ, Elliot JR, Donald RA, Espiner EA.
    N Z Med J; 1994 Feb 23; 107(972):52-3. PubMed ID: 8115069
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR, Ventz M, Diederich S, Quinkler M.
    J Clin Endocrinol Metab; 2012 Jan 23; 97(1):85-92. PubMed ID: 21994966
    [Abstract] [Full Text] [Related]

  • 8. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
    Camozzi V, Betterle C, Frigo AC, Zaccariotto V, Zaninotto M, De Caneva E, Lucato P, Gomiero W, Garelli S, Sabbadin C, Salvà M, Costa MD, Boscaro M, Luisetto G.
    Endocrine; 2018 Feb 23; 59(2):319-329. PubMed ID: 28795340
    [Abstract] [Full Text] [Related]

  • 9. An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid.
    Chikada N, Imaki T, Hotta M, Sato K, Takano K.
    Endocr J; 2004 Jun 23; 51(3):355-60. PubMed ID: 15256782
    [Abstract] [Full Text] [Related]

  • 10. Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease.
    Smans L, Lentjes E, Hermus A, Zelissen P.
    Hormones (Athens); 2013 Jun 23; 12(1):93-100. PubMed ID: 23624135
    [Abstract] [Full Text] [Related]

  • 11. [Introduction: Patients with primary adrenal insufficiency receive long - term glucocorticoid replacement therapy, which may cause osteoporosis].
    Vaňuga P, Ságová I.
    Vnitr Lek; 2021 Jun 23; 67(5):264-269. PubMed ID: 35459392
    [Abstract] [Full Text] [Related]

  • 12. Akinetic mutism followed by a manic reaction on introduction of steroid replacement for Addison's disease.
    Kalambokis G, Konitsiotis S, Pappas D, Tsianos EV.
    J Endocrinol Invest; 2006 Mar 23; 29(3):257-60. PubMed ID: 16682841
    [Abstract] [Full Text] [Related]

  • 13. Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report.
    Petersen KS, Rushworth RL, Clifton PM, Torpy DJ.
    BMC Endocr Disord; 2015 Oct 24; 15():61. PubMed ID: 26500000
    [Abstract] [Full Text] [Related]

  • 14. Glucocorticoid replacement therapy: are patients over treated and does it matter?
    Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R, Weetman AP.
    Clin Endocrinol (Oxf); 1997 Mar 24; 46(3):255-61. PubMed ID: 9156031
    [Abstract] [Full Text] [Related]

  • 15. Bone density and turnover in Addison's disease: effect of glucocorticoid treatment.
    Valero MA, Leon M, Ruiz Valdepeñas MP, Larrodera L, Lopez MB, Papapietro K, Jara A, Hawkins F.
    Bone Miner; 1994 Jul 24; 26(1):9-17. PubMed ID: 7950508
    [Abstract] [Full Text] [Related]

  • 16. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement.
    Ross IL, Levitt NS, Van der Walt JS, Schatz DA, Johannsson G, Haarburger DH, Pillay TS.
    Horm Metab Res; 2013 Jan 24; 45(1):62-8. PubMed ID: 22893258
    [Abstract] [Full Text] [Related]

  • 17. Co-morbidities, management and clinical outcome of auto-immune Addison's disease.
    Leelarathna L, Breen L, Powrie JK, Thomas SM, Guzder R, McGowan B, Carroll PV.
    Endocrine; 2010 Aug 24; 38(1):113-7. PubMed ID: 20960111
    [Abstract] [Full Text] [Related]

  • 18. BONE MINERAL DENSITY IN PATIENTS WITH ADDISON DISEASE ON REPLACEMENT THERAPY WITH PREDNISOLONE.
    Chandy DD, Bhatia E.
    Endocr Pract; 2016 Apr 24; 22(4):434-9. PubMed ID: 26684152
    [Abstract] [Full Text] [Related]

  • 19. [Cardiovascular and metabolic impact of glucocorticoid substitution therapy in patients with Addison's disease].
    Salah DB, Charfi N, Elleuch M, Kacem FH, Rekik N, Mnif M, Mnif F, Abid M.
    Pan Afr Med J; 2018 Apr 24; 30():251. PubMed ID: 30627312
    [Abstract] [Full Text] [Related]

  • 20. Addison's disease in pregnancy: Case report, management, and review of the literature.
    Margulies SL, Corrigan K, Bathgate S, Macri C.
    J Neonatal Perinatal Med; 2020 Apr 24; 13(2):275-278. PubMed ID: 31744021
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.